Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial.
Ali, Arwa
Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial. [electronic resource] - BMC cancer Apr 2020 - 342 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Observational Study
1471-2407
10.1186/s12885-020-06848-8 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Duration of Therapy
Female
Follow-Up Studies
Humans
Imidazoles--therapeutic use
Male
Melanoma--drug therapy
Middle Aged
Mutation
Oximes--therapeutic use
Prognosis
Proto-Oncogene Proteins B-raf--genetics
Retrospective Studies
Survival Rate
Tumor Burden--drug effects
Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial. [electronic resource] - BMC cancer Apr 2020 - 342 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Observational Study
1471-2407
10.1186/s12885-020-06848-8 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Duration of Therapy
Female
Follow-Up Studies
Humans
Imidazoles--therapeutic use
Male
Melanoma--drug therapy
Middle Aged
Mutation
Oximes--therapeutic use
Prognosis
Proto-Oncogene Proteins B-raf--genetics
Retrospective Studies
Survival Rate
Tumor Burden--drug effects